Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alana T Wong

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neuropsychologia|November 28, 2006
Remembering the past and imagining the future: common and distinct neural substrates during event construction and elaborationDonna Rose Addis, Alana T Wong, Daniel L Schacter
Psychological Science|January 10, 2008
Age-related changes in the episodic simulation of future eventsDonna Rose Addis, Alana T Wong, Daniel L Schacter
Journal of Cognitive Neuroscience|May 19, 2009
Age-related neural changes during memory conjunction errorsKelly S Giovanello, Elizabeth A Kensinger, Alana T Wong, et al.
Therapeutic Advances in Neurological Disorders|September 25, 2023
Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ studyAlasdair J Coles, Anat Achiron, Anthony Traboulsee, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neuropsychologia|November 28, 2006
Remembering the past and imagining the future: common and distinct neural substrates during event construction and elaborationDonna Rose Addis, Alana T Wong, Daniel L Schacter
Psychological Science|January 10, 2008
Age-related changes in the episodic simulation of future eventsDonna Rose Addis, Alana T Wong, Daniel L Schacter
Journal of Cognitive Neuroscience|May 19, 2009
Age-related neural changes during memory conjunction errorsKelly S Giovanello, Elizabeth A Kensinger, Alana T Wong, et al.
Therapeutic Advances in Neurological Disorders|September 25, 2023
Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ studyAlasdair J Coles, Anat Achiron, Anthony Traboulsee, et al.
Pageof 1